Filtered By:
Infectious Disease: Outbreaks
This page shows you your search results in order of date.
Order by Relevance | Date
Total 17 results found since Jan 2013.
Otolaryngology adverse events following COVID-19 vaccines
CONCLUSIONS: COVID-19 vaccine is of utmost importance in limiting the spread of SARS-CoV-2. Otolaryngology-related side effects have been described, but none was severe or life threatening. The mechanisms underlying these effects are still mostly unknown.PMID:35731083 | DOI:10.26355/eurrev_202206_28981
Source: Pharmacological Reviews - June 22, 2022 Category: Drugs & Pharmacology Authors: A Colizza M Ralli R Turchetta A Minni A Greco M de Vincentiis Source Type: research
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson & Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions. The study was sponsored by the Janssen Pharmaceutical Companies of Johnson & Johnson and conducted in partnership with the Department of Science-Aetion, Inc, and the Division of ...
Source: Johnson and Johnson - January 6, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
FDA Panel Greenlights First Single-Shot COVID-19 Vaccine, from Johnson & Johnson
The U.S. Food and Drug Administration’s (FDA) vaccine advisory committee earlier today (Feb. 26) voted unanimously to recommend Johnson & Johnson’s COVID-19 vaccine for emergency use authorization. While the FDA isn’t obligated to follow the committee’s advice, it generally does.
At the end of a full day of review and discussion of the company’s shot, all 22 voting members of the committee agreed that the vaccine was safe and effective enough to be used by the public. It’s the third vaccine that the group of independent experts has recommended, following Pfizer-BioNTech and Moderna. ...
Source: TIME: Health - February 27, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Audiovestibular symptoms and sequelae in COVID-19 patients
CONCLUSIONS: even if some patients suffer from audiovestibular symptoms, these are mostly transitory and there is no clear evidence of clinically relevant persistent cochlear or vestibular damage after recovery.PMID:33579886 | DOI:10.3233/VES-201505
Source: Journal of Vestibular Research: Equilibrium and Orientation - February 13, 2021 Category: Neuroscience Authors: Roberto Gallus Andrea Melis Davide Rizzo Antonio Piras Laura Maria De Luca Pierangela Tramaloni Antonello Serra Eleonora Longoni Giovanni Maria Soro Francesco Bussu Source Type: research
Telehealth tinnitus therapy during the COVID-19 outbreak in the UK: uptake and related factors
.
Source: International Journal of Audiology - September 30, 2020 Category: Audiology Authors: Hashir Aazh De Wet Swanepoel Brian C. J. Moore Source Type: research
